A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia

NCT02093325 ↗

Phase 3 Unknown 83 enrolled Chang Gung Memorial Hospital Novartis · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is evaluate the efficacy and safety of eltrombopag as a rescue of isolated chemotherapy-induced thrombocytopenia in patients with solid tumor .

Timeline

Start: 2014-03
Primary completion: 2019-03
Completion: 2019-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Eltrombopag	Small molecule	50 mg	—

A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia

Summary

Timeline

Drugs

Indications